Evidence map›Paper›PMID 42084919›Full record

ArticleThe Journal of clinical investigation2026

CXCR6+ CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infection.

Jason Nideffer, Florian Bach, Steven Strubbe, Luis Lopez, Maato Zedi, Felistas Nankya, Jessica Briggs, Kattria van der Ploeg, Kenneth Musinguzi, Soyeon Kim and 20 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Early enhanced control ofInfection and immunity · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Early enhanced control ofbioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Jason NidefferDepartment of Medicine and.
Florian BachDepartment of Medicine and.
Steven StrubbeDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, USA.
Luis LopezDepartment of Medicine and.
Maato ZediInfectious Diseases Research Collaboration, Kampala, Uganda.
Felistas NankyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Jessica BriggsDepartment of Medicine, Division of HIV, ID, and Global Medicine, UCSD, San Francisco, USA.
Kattria van der PloegDepartment of Medicine and.
Kenneth MusinguziInfectious Diseases Research Collaboration, Kampala, Uganda.
Soyeon KimDepartment of Medicine and.
Aracely Garcia RomeroDepartment of Medicine and.
Arefin KeyaDepartment of Medicine, Division of HIV, ID, and Global Medicine, UCSD, San Francisco, USA.
Kylie CamanagDepartment of Medicine and.
Savannah LewisDepartment of Medicine and.
Muhammad AbdelbassetDepartment of Medicine and.
Bing WangDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, USA.
Allison BossDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, USA.
Evelyn NansubugaInfectious Diseases Research Collaboration, Kampala, Uganda.
Joaniter I NankabirwaInfectious Diseases Research Collaboration, Kampala, Uganda.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
Saki TakahashiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Grant DorseyDepartment of Medicine, Division of HIV, ID, and Global Medicine, UCSD, San Francisco, USA.
Bryan GreenhouseDepartment of Medicine, Division of HIV, ID, and Global Medicine, UCSD, San Francisco, USA.
Isabel Rodriguez-BarraquerDepartment of Medicine, Division of HIV, ID, and Global Medicine, UCSD, San Francisco, USA.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Rosa BacchettaDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, USA.
Isaac SsewanyanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Ashraful HaqueDepartment of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia.
Maria Grazia RoncaroloDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, USA.
Prasanna JagannathanDepartment of Medicine and.

Funding

Computational models of naturally acquired immunity to falciparum malariaU01AI150741 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUTTE, ATUL J, GREENHOUSE, BRYAN R · 2020 to 2024
$7.4M
Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsR01AI177377 · NIAID · STANFORD UNIVERSITY · PI Ashraful Haque, Prasanna Jagannathan · 2024 to 2026
$2.0M
NIAID NIH HHS R01 AI177377NIAID NIH HHS U01 AI150741
6 · The paper itself

Abstract

Plasmodium falciparum (Pf) induces the clonal expansion of antigen-specific type 1 regulatory T (Tr1) cells capable of long-term memory. Tr1 cells comprise nearly 90% of the Pf blood stage antigen-specific CD4+ T cell pool in children. Though, whether Tr1 cells contribute to protection from malaria remains undetermined. To address this critical knowledge gap, we first performed scRNA-seq on gated cell populations and validated CXCR6+ CD127- as new phenotypic markers to enrich for bona fide Tr1 cells. Importantly, these Tr1 cells potently suppressed the proliferation of other CD4+ T cells in vitro via IL-10 secretion. Among children living in malaria-endemic Uganda, CXCR6+ CD127- Tr1 cells were the dominant responding subset to Pf-infected red blood cell stimulation in vitro. They also rapidly expanded following malaria and expressed IL-10 and IFN-γ during infection in vivo. Tr1 abundance correlated with plasma concentrations of granzyme A, IFN-γ, IL-10, and LAG3, suggesting that these cells act systemically. Higher CXCR6+ CD127- Tr1 cell frequencies correlated with a lower probability of symptoms given parasitemia but were also associated with delayed parasite clearance among untreated, asymptomatic children. These data suggest that Tr1 cells help mediate clinical immunity to malaria but may also facilitate parasite persistence through mechanisms of immune regulation.

Indexed as

Interleukin-7 Receptor alpha SubunitMalaria, FalciparumPlasmodium falciparumReceptors, CXCR6T-Lymphocytes, RegulatoryChildChild, PreschoolFemaleHumansInterleukin-10MaleCXCR6 protein, humanInterleukin-10Interleukin-7 Receptor alpha SubunitReceptors, CXCR6Cellular immune responseImmunologyInfectious diseaseMalariaT cells

Identifiers

PMID42084919
PMCPMC13367961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.